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It has been widely demonstrated that the human immunodeficiency virus type 1 (HIV-1) envelope, specifically the V3 loop
of the gp120 spike, evolves to facilitate adaptation to different cellular populations within an infected host. Less energy has
been directed at determining whether the viral promoter, designated the long terminal repeat (LTR), also exhibits this adaptive
quality. Because of the unique nature of the cell populations infected during the course of HIV-1 infection, one might expect
the opportunity for such adaptation to exist. This would permit select viral species to take advantage of the different array
of conditions and factors influencing transcription within a given cell type. To investigate this hypothesis, the function of
natural variants of the NF-kB-proximal Sp element (Sp site III) was examined in human cell line models of the two major cell
types infected during the natural course of HIV-1 infection, T cells and monocytes. Utilizing the HIV-1 LAI molecular clone,
which naturally contains a high-affinity Sp site III, substitution of low-affinity Sp sites in place of the natural site III element
markedly decreased viral replication in Jurkat T cells. However, these substitutions had relatively small effects on viral
replication in U-937 monocytic cells. Transient transfections of HIV-1 LAI-based LTR-luciferase constructs into these cell
lines suggest that the large reduction in viral replication in Jurkat T cells, caused by low-affinity Sp site III variants, may result
from reduced basal as well as Vpr- and Tat-activated LTR activities in Jurkat T cells compared to those in U-937 monocytic
cells. When the function of Sp site III was examined in the context of HIV-1 YU-2-based LTR-luciferase constructs,
substitution of a high-affinity element in place of the natural low-affinity element resulted in increased basal YU-2 LTR activity
in Jurkat T cells and reduced activity in U-937 monocytic cells. These observations suggest that recruitment of Sp family
members to Sp site III is of greater importance to the function of the viral promoter in the Jurkat T cell line as compared to
the U-937 monocytic cell line. These observations also suggest that other regions of the LTR may compensate for Sp
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INTRODUCTION
Isolates of human immunodeficiency virus type 1
(HIV-1) exhibit marked differences in their ability to rep-
licate in primary macrophages and T cell lines in vitro.
Macrophage-tropic (M-tropic) non-syncytium-inducing
(NSI) variants of HIV-1 replicate efficiently in primary T
cells and macrophages but not in transformed T cell
lines. T-cell-tropic (T-tropic) syncytium-inducing (SI) vari-
ants of HIV-1 replicate efficiently in primary T cells and in
transformed T cell lines but not in primary macrophages.
Restricted replication in these cell types is frequently
associated with viral entry, a process regulated by inter-
actions between the viral envelope gene product (gp 120)
and CD4 in conjunction with certain chemokine recep-
tors (reviewed in Berger et al., 1999 and Clapham, 1999).
Sequence alterations in the V3 loop of gp120 are thought
to facilitate changes in cellular tropism by altering the
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affinity for particular coreceptor molecules (O’Brien et al.,
1990; Hwang et al., 1991; Shioda et al., 1991). HIV-1
ariants containing V3 loop sequences recognizing the
CR5 chemokine coreceptor (designated R5 strains) are
trongly correlated with the M-tropic, non-syncytium-in-
ucing phenotype, whereas variants containing se-
uences recognizing the CXCR4 chemokine coreceptor
designated X4 strains) are strongly correlated with the
-tropic, syncytium-inducing phenotype (Speck et al.,
997).
Although viral entry is critical for replication to pro-
eed, there are indications that HIV-1 cellular tropism is
ot solely determined by the structure of the viral gp120.
himeric viral constructs containing the V3 region of an
-tropic R5-dependent envelope (strain 89.6) in a T-
ropic X4-dependent viral backbone (strain HXB) indi-
ated that, although entry into primary macrophages was
ediated by the R5 V3 loop, replication was blocked at a
ostentry step (Smyth et al., 1998). Replication approach-
ng that of the parental 89.6 construct was achieved in an
XB-based chimeric construct upon transfer of a 2.7-kb
egion of 89.6 genome containing tat, rev, vpu, env, nef,
nd the 39 U3 region of the LTR (Kim et al., 1995).
lthough subparental levels of replication were achieved
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ION OFfollowing the exchange of smaller regions of the 89.6
genome, complete elimination of the postentry block, as
shown by Smyth and coworkers (1998), required the
transfer of multiple nonenvelope factors, suggesting that
several nonenvelope factors may play an important role
in generating the M-tropic phenotype. In addition, a more
recent report has shown that X4 variant viruses can enter
macrophages utilizing low levels of naturally expressed
CXCR4 chemokine receptor, but fail to initiate a produc-
tive replication cycle as the result of a postentry block
(Schmidtmayerova et al., 1998). The results indicated that
two non-envelope-based factors contributed to the block.
Specifically, the X4 variant viruses exhibited an alteration
in the kinetics of reverse transcription and a fivefold
reduction in nuclear import as compared to R5 viruses.
HIV-1 cellular tropism may play an important role in
disease progression. The primary and clinically latent
stages of infection are associated with viral species
exhibiting M-tropic NSI replication characteristics
(Schuitemaker et al., 1991; Valentin et al., 1994),
whereas clinical disease progression is associated
with the development of viral species exhibiting T-
tropic SI replication characteristics (Connor and Ho,
1994; Schuitemaker et al., 1992). The in vivo adaptation
of M-tropic viral species to a species exhibiting more
T-tropic characteristics is likely driven, in part, by the
selective pressure of the host immune system acting
in conjunction with the natural variation of the HIV-1
genome (Delwart et al., 1994; Lukashov et al., 1995).
This process is facilitated by the ability of the virus to
generate genomic sequence variation through a high
level of viral replication coupled with the low fidelity of
the viral reverse transcriptase enzyme (Pang et al.,
1992; Ewald, 1994).
A potential site for postentry adaptation is the viral
long terminal repeat (LTR), which, in its 59 position in
the proviral genome, serves as the promoter for viral
gene expression (Cullen, 1991; Jones and Peterlin,
1994). Interactions between the cis-acting elements
present in the viral promoter and cellular transcription
factors present in the host cell influence the rate of
viral gene expression under a wide variety of condi-
tions including cellular stimulation, division, and dif-
ferentiation. The core viral promoter is comprised of a
TATAA box and three Sp family binding sites. This
region is necessary for efficient basal transcription
and thus essential for the function of HIV-1 proviral
DNA-mediated gene expression. Immediately up-
stream of the three Sp elements is the enhancer re-
gion, comprising two inducible NF-kB binding sites.
This region, although not absolutely necessary for
viral replication, responds to cellular activation signals
by stimulating LTR activity and increasing the rate of
viral production. Upstream of the enhancer region lies
DIFFERENTIAL UTILIZATthe modulatory region, which contains numerous tran-
scription factor binding sites that may increase or
s
adecrease transcription. LTR activity is also enhanced
by the viral Tat protein (Arya et al., 1985). Tat-mediated
transactivation of the LTR requires an interaction be-
tween Tat and an RNA stem-loop structure, termed the
transactivation response element (TAR) (reviewed by
Jones and Peterlin, 1994). Tat transactivation may also
be influenced by Sp elements in the core promoter.
The loss of Sp elements in the HIV-1 LTR dramatically
reduces Tat-mediated LTR activity (Harrich et al.,
1989). In addition, the Tat-inducibility of certain syn-
thetic promoters has been shown to be Sp1-depen-
dent (Kamine et al., 1991). Sp sites within the viral core
promoter have also been shown to be important in
mediating LTR transactivation by the viral accessory
protein Vpr (Wang et al., 1995). Overall, Sp elements
within the core viral promoter have been shown to
comprise a critical region of the viral promoter and
thus represent at least one region, which could be
subject to sequence variation that facilitates viral ad-
aptation to a given cellular environment, leading to
enhanced viral replication under select intracellular
conditions.
Several studies have reported that the LTR may evolve
independently in different tissues, thereby implicating
the LTR as a potential contributor to cell type-specific
gene expression and viral replication. Some evidence,
though indirect, was provided by phylogenetic analyses
of HIV-1 sequences derived from different tissues (Ait-
Khaled et al., 1995; Corboy and Garl, 1997), as well as a
functional approach that examined tissue- and cell type-
specific LTR-directed transgene expression in mice (Cor-
boy et al., 1992). More direct evidence of LTR involve-
ment in cell type-specific viral replication was provided
by the finding that viral replication in primary monocytes,
but not primary T cells, requires the presence of intact
C/EBP sites within the viral LTR (Henderson and Calame,
1997). These findings demonstrated that cis-acting ele-
ments within the LTR may exhibit different patterns of
utilization in T cells and monocytes, evidence that is
consistent with the hypothesis that cell type-specific
transcription factor or factor combinations can be utilized
by properly adapted viral promoter structures to contrib-
ute to HIV-1 tropism.
Evidence presented herein suggests that the relative
affinity of the NF-kB-proximal Sp element for Sp factors
nd its impact on viral replication is influenced by the cell
ype in which the virus replicates. These studies indicate
hat weak Sp binding sites are of greater detriment to
irus replication in the Jurkat T cell line than they are to
irus replication in the U-937 monocytic cell line. Addi-
ional evidence is presented which suggests that the
mpact on viral replication can be attributed to cell type-
263HIV-1 LTR Sp SITE IIIpecific differences in basal, as well as Vpr- and Tat-
ctivated, LTR activity.
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2 ISTERRESULTS
he G/C-rich elements of PBMC-derived HIV-1 LTRs
xhibit a high degree of nucleotide sequence
onservation
The location of the Sp array in the HIV-1 LTR is shown
elative to additional transcriptional control elements
FIG. 1. Location of cis-acting Sp elements in the HIV-1 LTR and
elative conservation of nucleotide sequence. (A) Relative location of
he Sp sites and additional elements in the HIV-1 LTR. Not all the
lements described in the literature are indicated. (B) LTR sequences
ere aligned and compared to the clade B consensus sequence. The
requency of occurrence of a non-clade B nucleotide was calculated at
ach nucleotide position for each individual as a percentage of total
TRs examined from each individual. The mean nonconsensus fre-
uency (NCF) was calculated from these values at each nucleotide
osition for the population of individuals and plotted above the con-
ensus sequence. The nucleotide changes most often observed were
pparent nucleotide substitutions, although insertions and deletions
id occur at certain positions and these were also included as a
ucleotide change in this analysis. (C) The mean nonconsensus fre-
uencies for each 10-bp Sp site and the entire Sp region are shown.
64 MCALLFig. 1A). To investigate the general level of nucleotide
ariation within the G/C-rich region containing the cis-
t
tcting Sp elements, PBMC-derived LTR sequences from
hree large published studies were compiled and ana-
yzed (Estable et al., 1996; Kirchhoff et al., 1997; Michael
t al., 1994). Each study contained multiple LTRs derived
rom four or more individuals that resided within North
merica for a total of 150 sequences derived from 45
ndividuals. The analysis was conducted by first exam-
ning the LTRs of each individual separately, to calculate
he frequency of nonconsensus nucleotides at each nu-
leotide position as a percentage of total LTRs examined
rom the individual. The mean frequency of nonconsen-
us nucleotides of all individuals (nonconsensus fre-
uency, NCF) at each nucleotide position in the Sp array
egion was determined. This information was plotted as
bar graph above the clade B consensus sequence (Fig.
B).
At each nucleotide position in the array (including
lanking sequence at both ends), the most common nu-
leotide matched the consensus for HIV-1 clade B, the
ost common HIV-1 subtype in North America. Per nu-
leotide NCFs were averaged over the entire Sp array
Sp site III, II, and I, including flanking sequence) and
ithin individual 10-bp Sp sites, to express an overall
evel of sequence variation for both the region and each
ndividual site (Fig. 1C). Over the entire region, variation
ithin the Sp array was shown to be very low, with a
ean regional NCF of 3.4% (Fig. 1C). By way of compar-
son, the 39 NF-kB element exhibited a mean NCF of 6.3%
data not shown). The highly conserved nature of this
egion underscores its importance in viral gene regula-
ion and replication. Of the three individual sites, varia-
ion is lowest in site I (1.3% mean NCF), intermediate in
ite II (2.7% mean NCF), and highest in site III (6.6% mean
CF). Since it was of interest to determine how natural
equence variation might affect viral gene expression
nd replication in the different cell populations which
ypically serve as hosts for HIV-1 infection, the impact of
equence variation within the most variable element, the
F-kB-proximal Sp site III, was selected for initial stud-
ies.
To identify naturally occurring HIV-1 LTR Sp site III
variants which were likely to impact factor recruitment
and transcriptional function, the Sp consensus binding
site derived from analysis of 108 published Sp factor
binding sites (TRANSFAC) (Heinemeyer et al., 1999) was
xamined (Fig. 2). The strongest conservation occurs
ear the center of the Sp binding site at positions 3–6
GCGG) within the 10-bp element. With the exception of
he central C nucleotide (position 5), which is often a T or
n A but never a G, the surrounding three guanine
ucleotides are conserved in nearly all known Sp bind-
ng sites. Moreover, the guanine residue at position four
f the consensus Sp site appeared to be imperative for
aximizing factor recruitment, since no studies of effec-
ET AL.ive Sp binding sites containing any other nucleotide at
his position have been reported. Based on this informa-
n
f
K
ucleoti
pact oftion, two variant sites that exhibit alterations of the gua-
nine at position four were selected. Specifically, the Sp
site III from HIV-1 YU-2, a brain-derived M-tropic R5-
dependent molecular clone (Li et al., 1991), and the p4del
atural variant, a sequence variant found in LTRs ampli-
ied from lung tissue of an HIV-1-infected patient (Ait-
haled et al., 1995), were used in subsequent studies
(Fig. 2).
Selected Sp site III variants exhibit weak Sp factor
recruitment
The Sp family of transcription factors includes a num-
ber of closely related proteins, including Sp1, Sp3, and
Sp4. To identify the specific Sp family members present
in U-937 monocytic and Jurkat lymphocytic nuclear ex-
tract, electophoretic mobility shift (EMS) analyses were
conducted with the high-affinity clade B consensus Sp
site III (LIII, Fig. 3A) as a radiolabeled probe. In both
cases, four distinct DNA–protein complexes were ob-
served (Fig. 3B; lanes 1 and 6). In the presence of
antibody directed against Sp1, a majority of complex A
was replaced by a lower-mobility complex (Fig. 3B; lanes
2 and 7). Complexes B and C were shown to be reactive
with antibody directed against Sp3 by abrogation or
abrogation coupled with mobility shift (Fig. 3B; lanes 3
and 8). Consistent with the analysis of individual anti-
bodies, the use of both Sp1 and Sp3 antisera resulted in
the shift or abrogation of complexes A, B, and C (Fig. 3A;
FIG. 2. Comparison of consensus Sp binding element with respect t
nucleotide encountered at a given position within the consensus Sp bin
Sp site III (Clade B cons.), the LAI-derived Sp site III (LIII), the YU-2-de
similar to those found in YU-2 (p4del). By comparing the positions of n
alterations within the consensus Sp element one can estimate the im
DIFFERENTIAL UTILIZATlanes 4 and 9). Sp4 antisera did not react significantly
with any of the observed complexes (Fig. 3A; lanes 5 and10). Complex D was unaffected by the presence of any of
the Sp antisera examined, and has been shown to be
nonspecific by competition with homologous and nonho-
mologous competitors (data not shown).
The ability of selected naturally occurring variants of
HIV-1 Sp site III to bind Sp family transcription factors
was examined in vitro utilizing both direct binding and
competition EMS analysis. First, U-937 monocytic and
Jurkat lymphocytic nuclear extracts were reacted with
radiolabeled probes containing the clade B consensus
Sp site III, the YU-2-derived Sp site III, and the p4del
variant Sp site III (Fig. 3A; LIII, YIII, and p4del, respec-
tively). Strong Sp1- and Sp3-containing DNA–protein
complexes were observed when the LIII probe was re-
acted with either U-937 or Jurkat nuclear extracts (Fig.
3C; lanes 1 and 4). In the presence of either nuclear
extract, the use of the variant Sp site III elements (YIII
and p4del) resulted in a significant reduction in complex
formation as compared to the clade B consensus (LIII)
Sp element (Fig. 3C; compare lane 1 to lanes 2 and 3,
and lane 4 to lanes 5 and 6). Although the use of variant
Sp site III elements (YIII and p4del) resulted in the gen-
eration of little or no Sp-containing DNA–protein com-
plexes in the presence of U-937 nuclear extract (Fig. 3C;
lanes 2 and 3), low-intensity Sp-containing DNA–protein
complexes were observed in the presence of Jurkat
nuclear extract (Fig. 3C; lanes 5 and 6). In addition,
Sp-related complex formation was greater in the pres-
IV-1 Sp elements examined. Bar graph depicts the frequency of each
lement. Also depicted are four HIV-1 elements: the clade B consensus
p site III (YIII), and a natural variant Sp site III containing sequences
de alterations within the Sp site III variants to the frequencies of such
a given nucleotide alteration on factor recruitment.
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ION OFence of the p4del Sp site III element than in that of the
YIII element. This difference was readily apparent in
wde B c
d the preactions containing Jurkat nuclear extract (Fig. 3C; com-
pare lanes 5 and 6), and could also be detected in
reactions containing U-937 nuclear extract following
FIG. 3. Comparison of the affinity of Sp factors for different Sp site
oligonucleotides used in EMS analyses are represented by bars draw
indicated with the nucleotide substitution shown. A dash indicates a d
Sp site III were performed as described under Materials and Methods
ith 1 ng radiolabeled probe (approximately 60,000 cpm). Antisera (1 m
whereas supershifted DNA–protein complexes are indicated with arrow
cells was incubated with labeled clade B consensus Sp site III probe
reactions as indicated at molar equivalents of 5-, 25-, 50-, 100-, and 20
correspond to the LAI-derived Sp site III, which is equivalent to the cla
(con BI, lanes 8–12), the YU-2-derived Sp site III (YIII, lanes 14–18), an
266 MCALLlonger autoradiographic exposures (data not shown).
Hence, the p4del Sp site III appears to be intermediatebetween the clade B consensus and the YIII element in
its ability to recruit Sp factors. In addition to quantitative
differences in Sp-related complex formation, the Sp3-
ts by competition EMS analyses. (A) The sequences of the four DNA
the clade B consensus sequence. Changes from the consensus are
of the nucleotide. EMS analyses using the HIV-1 clade B consensus
C) Binding reactions included 6 mg of U-937 or Jurkat nuclear extract
added as indicated. DNA–protein complexes are labeled A through D,
n equal amount of nuclear extract (6 mg) derived from Jurkat or U-937
) in all reactions. Specific competitor oligonucleotides were added to
excess compared to labeled probe in each reaction. The competitors
onsensus Sp site III (LIII, lanes 2–6), the clade B consensus Sp site I
4del Sp site III (p4del, lanes 19–24).
ET AL.varian
n below
eletion
. (B and
l) was
s. (D) A
(0.5 ng
0-fold
ISTERcontaining complex C exhibited alterations in mobility,
which were dependent on the Sp site III probe utilized
m
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ION OF(Fig. 3C; compare lanes 5 and 6). The observed differ-
ence in DNA–protein complex formation between the
two variant Sp elements may be the result of a se-
quence-dependent binding of the two recently proposed
Sp3 isoforms (Suske, 1999; Kennett et al., 1997)
To more clearly examine the relative ability of each Sp
site III element to bind Sp factors, the high-affinity clade
B consensus Sp site III (LIII), the low-affinity clade B
consensus site I (con BI), the YU-2-derived Sp site III
(YIII), and the p4del variant Sp site III (p4del) were used
as competitor DNAs with respect to factor binding to the
radiolabeled clade B consensus Sp site III element (LIII).
These studies were performed using nuclear extracts
derived from Jurkat T cells and U-937 monocytic cells. In
both cases, the clade B consensus Sp site III acted as a
highly efficient competitor, while the low-affinity clade B
consensus site I acted as a very inefficient competitor
(Fig. 3B; compare LIII, lanes 1–6, to con BI, lanes 7–12).
Consistent with the direct binding studies, the YU-2-
derived Sp site III exhibited little, if any, ability to compete
with the clade B consensus probe using either Jurkat or
U-937 nuclear extracts (Fig. 3B; YIII, lanes 13–18). The
p4del variant Sp site III competed less efficiently than the
low-affinity clade B consensus site I, but more efficiently
than the YU-2-derived Sp site III (Fig. 3B; compare p4del,
lanes 19–24, to con BI and YIII, lanes 7–12 and 13–18,
respectively). In summary, both the YU-2-derived and
p4del variant Sp site III exhibited binding phenotypes
characterized by weak factor recruitment.
Replication of recombinant LAI-based HIV-1
molecular clones containing the YU-2 and p4del Sp
site III configurations
To directly determine whether the YU-2 and p4del Sp
sites alter viral replication, these elements were intro-
duced into the HIV-1 LAI molecular clone and viral rep-
lication was examined in the Jurkat lymphocytic and
U-937 monocytic cell lines. In Jurkat cells, the replication
rate of both mutant viruses was significantly lower than
that of the parental LAI strain (Fig. 4A). The LAI-p4 HIV-1
variant exhibited a 6-day lag phase before detectable
levels of p24 were produced. Although this delay does
not appear to significantly alter the slope of the viral
replication curve, it was associated with a reduction in
the magnitude of p24 production by nearly 3 logs be-
tween mutant and parental viruses at each time point
examined. The LAI-YIII virus did not generate any detect-
able p24 production at the time points examined. These
data clearly demonstrate that the rate of HIV-1 replication
in the T cell line was severely affected when the high-
affinity clade B consensus Sp site III was converted to an
element with lower affinity. However, when this experi-
ment was performed in the U-937 monocytic cell line, the
DIFFERENTIAL UTILIZATreplication of the parental and mutant viruses was more
comparable (Fig. 4B). At Day 12 postinfection the LAI-p4virus was found to generate approximately 42% of the
p24 produced by the parental LAI molecular clone,
whereas the LAI-YIII virus produced 18% of the p24 of the
parental virus. Therefore, a comparison of the replication
rates of the two viruses in Jurkat T cells and U-937
monocytic cells leads to the conclusion that the absence
of a highly functional Sp site III in LAI is of greater
detriment in T cells than it is in monocytic cells.
In both cell lines, the replication rate of the mutant
viruses correlated with the binding affinity of the Sp site
III elements (Fig. 3B), suggesting that differences in viral
replication may be caused by differences in Sp factor
occupancy at the Sp site III. Because of the prominent
FIG. 4. Replication of HIV-1 molecular clones containing variant Sp
site III. Replication of variant viruses in Jurkat T cells and U-937
monocytic cells facilitates a comparison of their replication compe-
tence relative to parental LAI. (A) Replication profile resulting from the
infection of 3 3 106 Jurkat T cells with 200 pg of input virus. Supernatant
samples were taken at 2-day intervals and assayed for p24 production
by ELISA. Cells were reseeded into new media at their original plating
density at each time point shown. Viruses depicted include parental
LAI (LAI), a variant LAI virus containing the YU-2-derived Sp site III
(LAI-YIII), and a variant virus containing the p4del Sp site III (LAI-p4del).
(B) Viral replication resulting from the infection of 1 3 106 U-937
onocytic cells with 100 ng of input virus. Supernatant samples were
aken at 3-day intervals and assayed for p24 production by ELISA. Cells
ere reseeded into 50% new media at their original plating density at
ach time point shown. Viruses depicted include parental LAI (LAI), a
ariant LAI virus containing the YU-2-derived Sp site III (LAI-YIII), and a
ariant virus containing the p4del Sp site III (LAI-p4del).
267HIV-1 LTR Sp SITE IIIroll played by the Sp elements in HIV-1 LTR-directed
transcription, cell type-specific differences in viral repli-
e
t
ISTERcation might be the result of altered basal transcription,
Tat-induced transcription, Vpr-induced transcription, or
some combination of the three possibilities.
Variant cis-acting Sp elements affect basal HIV-1
LTR-mediated gene expression
To examine the impact of the YU-2-derived Sp site III
and the p4del natural variant Sp site III on LTR-mediated
gene expression, LTR-luciferase constructs were gener-
ated for use in transient transfection–reporter gene ex-
pression analyses. Utilizing the HIV-1 LAI LTR as a back-
bone, constructs were generated containing the naturally
occurring YU-2-derived Sp site III (LAI-YIII) and the p4del
Sp site III (LAI-p4) variants. In addition, the HIV-1 YU-2
LTR was utilized as a backbone to generate constructs
containing the LAI-derived (clade B consensus) Sp site
III (YU-2-LIII) and the p4del variant Sp site III (YU-2-p4)
(Fig. 5A). Each construct was examined for activity in the
Jurkat T and U-937 monocytic cell lines. When compared
to the activity of the LAI LTR construct, a 58% reduction
in LTR activity was observed in Jurkat cells with the
introduction of the YIII Sp site III. However, this reduction
in activity was found to be less severe in U-937 cells, in
which the LAI-YIII construct exhibited a 27% decrease in
LTR activity (Fig. 5B; LAI-YIII). These results were consis-
tent with the results obtained in the viral replication
studies (Figs. 4A and 4B), in that the detrimental effect of
the YIII Sp site III on basal LTR activity is greater in Jurkat
cells than in U-937 cells. When the LTR containing the
p4del Sp site III was examined in the two cell lines,
activity in both lines was reduced by approximately 34%
(Fig. 5B; LAI-p4).
The YU-2 LTR was utilized to examine the effect of a
high-affinity NF-kB-proximal cis-acting Sp element on
activity of an LTR which naturally contains a weak Sp
element. Unexpectedly, a strong Sp site III appears to be
detrimental to YU-2 LTR activity in U-937 cells. The intro-
duction of the LIII Sp site III decreased YU-2 LTR activity
in U-937 cells by 61%. In contrast, the high-affinity LIII Sp
site increased YU-2 LTR activity fivefold in Jurkat cells
(Fig. 5C; YU-2-LIII). In U-937 cells, introduction of the
p4del variant Sp site III into the YU-2 LTR generated little
change in activity from the parental YU-2 LTR (Fig. 5C;
YU-2-p4). This minor difference in activity was consistent
with the small difference in binding affinity between the
two Sp elements (YIII and p4del). However, the differ-
ence was more significant when the same constructs
were compared in the Jurkat cell line. Here, the activity of
the YU-2 construct was increased twofold in the pres-
ence of the LIII Sp site (Fig. 5C; YU-2-p4). Overall, the
results generated from the YU-2-based LTR constructs
suggest that a high-affinity NF-kB-proximal Sp site III is
268 MCALLimportant for basal LTR function in Jurkat T cells, but
detrimental in U-937 monocytic cells. In addition, it sug-gests that the YU-2 LTR may be regulated differently than
the LAI LTR.
Variant cis-acting Sp elements affect Vpr-induced
HIV-1 LTR-mediated gene expression
Utilizing the same series of LTR-luciferase constructs
shown in Fig. 5A, the impact of the NF-kB-proximal Sp
lement was examined with respect to LTR transactiva-
ion by the HIV-1 accessory gene vpr. Since previous
FIG. 5. Transient expression analysis of Sp site III variants in the
context of the HIV-1 LAI and YU-2 LTRs. (A) Diagrammatic depiction of
the LTR-luciferase constructs examined. Standard reporter gene as-
says utilizing the dual luciferase reporter system (see Materials and
Methods for details) were employed to determine the effect of the
YU-2-derived Sp site III (LAI-YIII), and the p4del natural variant Sp site
III (LAI-p4) on parental LAI (LAI) LTR function (B). In addition, the effects
of the LAI and p4del Sp sites in the context of the YU-2 LTR were also
examined (C). Results comparing the activity of constructs in both the
Jurkat T cell line and the U-937 monocytic line are shown as a per-
centage of parental LTR activity. Raw luminescence readings for the
LAI construct ranged between 75,824 and 117,725 as compared to
background reading, which ranged between 50 and 53 in Jurkat cells.
CMV-pRL Renilla values for those same transfections ranged from
65,764 to 112,968 as compared to background readings, which ranged
from 1788 to 2002. In U-937 cells, LAI LTR-luc ranged from 7430 to
19592 relative to background readings, which ranged between 43 and
52, whereas TK-pRL ranged from 18,791 to 38,368 as compared to
background levels of 1500 to 2149.
ET AL.reports have indicated that Vpr-driven LTR transactiva-
tion is mediated through the G/C box array of the HIV-1
for those same transfections ranged from 49,098 to 103,710 as compared
to background readings, which ranged from 1891 to 2639. In U-937 cells,
ION OFLTR (Wang et al., 1995), it follows that constructs con-
taining variant Sp site III elements might exhibit altered
levels of Vpr induction. It was further hypothesized that
Vpr might induce transactivation of the LTRs containing
the YIII and p4del Sp site III configurations in a cell
type-specific manner.
The HIV-1 LAI- and YU-2-based constructs were ex-
amined in cotransfection experiments utilizing expres-
sion constructs for Vpr (strain 89.6) and a mutant Vpr
(R73S) containing an amino acid substitution known to
inactivate Vpr-mediated transactivation of the HIV-1 LTR
(Sawaya et al., 1999). These studies indicated that R73S
Vpr did not significantly alter the relative activities of the
LTR-luciferase constructs examined (compare Figs. 6A
and 6B to 5B and 5C). In the presence of the transacti-
vating Vpr, LAI LTR activity was elevated 12.8-fold in
Jurkat T cells and 14.5-fold in U-937 cells (Fig. 6E; LAI).
Relative activities of LAI, LAI-YIII, and LAI-p4 were similar
to those observed under nontransactivating conditions
(compare Figs. 6C and 6A). A small reduction (19%) in LAI
LTR activity was observed with introduction of the YIII Sp
site III in U-937 cells, whereas a larger reduction in LAI
activity (64%) was observed in Jurkat cells (Fig. 6C; LAI-
YIII). Similarly, when the p4del Sp site III was examined,
a 19% reduction in LAI LTR activity was observed in
U-937 cells, whereas a 45% reduction was observed in
Jurkat cells (Fig. 6C; LAI-p4).
The YU-2 LTR-based constructs were also examined
in the presence of Vpr. In U-937 cells, YU-2 LTR activity
was 24% lower than LAI LTR activity, but the presence of
Sp site III variants had little effect on YU-2 activity in the
presence of Vpr (Fig. 6D; YU-2, YU-2-LIII, and YU-2-p4).
Conversely, the Sp site III variants had a greater affect on
YU-2 LTR activity in the Jurkat T cell line. Although YU-2
LTR activity was 56% lower than that exhibited by the LAI
LTR, introduction of the Sp site III from the LAI LTR into
the YU-2 construct (YU-2-LIII) increased LTR activity by
about twofold. Introduction of the p4del Sp site III had
little effect on YU-2 LTR activity in the presence of Vpr. In
summary, these results suggest that in the presence of
Vpr, the activity of LAI and YU-2 LTR is more dependent
on a high-affinity cis-acting Sp site III in Jurkat T cells
than in U-937 monocytic cells. These results are consis-
tent with the observation that the recombinant HIV-1 LAI
molecular clones containing the YU-2- and p4-derived
natural variants of the Sp site III replicated closer to
parental levels in U-937 cells as compared to replication
in Jurkat cells.
Results were also expressed as Vpr-mediated fold-
induction for each of the constructs examined. For each
LAI LTR-luc ranged from 22,266 to 38,187 (uninduced) and 283,941 to
450,663 (induced) relative to background readings, which ranged be-
269HIV-1 LTR Sp SITE IIIFIG. 6. Transient expression analysis of the Sp site III variants during
transactivation by Vpr. Standard reporter gene assays utilizing the dual
luciferase reporter system (see Materials and Methods for details) were
employed to determine the effect of cotransfected Vpr on the YU-2-derived
Sp site III (LAI-YIII), and the p4del natural variant Sp site III (LAI-p4) in the
context of parental LAI (LAI) LTR function (A and C). In addition, the effects
of Vpr cotransfection on the clade B consensus (YU-2-LIII) and p4del
natural variant (YU-2-p4) sites in the context of the YU-2 LTR, which
naturally carries the YU-2-derived Sp site III, were examined (B and D). A
comparison of activity of the constructs in both the Jurkat T cell line and the
U-937 monocytic line in the presence of cotransfected Vpr R73S is shown
(A and B). R73S is a mutant Vpr construct, which exhibited no transacti-
vating capacity for the HIV-1 LTR; thus this figure approximates the basal
activity shown in Fig. 5. Results are shown as a percentage of parental LTR
activity. (C and D) A comparison of the ability of cotransfected Vpr to
transactivate each of the variant LTR constructs is shown in both the Jurkat
T cell and the U-937 monocytic cell lines. Results are presented as a
percentage of Vpr-induced parental LTR activity. (E) The fold-induction by
Vpr of each variant Sp site III construct is shown. Fold-induction was
calculated by dividing LTR activity in the presence of Vpr 89.6 by LTR
activity in the presence of Vpr R73S. Raw luminescence readings for the
LAI construct ranged between 107,538 and 130,206 (uninduced) and
1,736,160 and 2,080,572 (induced) as compared to background reading,
which ranged between 44 and 564 in Jurkat cells. CMV-pRL Renilla values
DIFFERENTIAL UTILIZATtween 57 and 72, whereas TK-pRL ranged from 56,064 to 77,727 as
compared to background levels of 2148 to 2495.
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from 2127 to 2250. In U-937 cells LAI LTR-luc ranged from 5302 and 46,073
(uninduced) and 2,241,562 and 3,086,130 (induced) relative to back-
ISTERof the LAI-based constructs (LAI, LAI-YIII, and LAI-p4)
fold-induction by Vpr was very similar (14- to 16-fold) in
both Jurkat and U-937 cell lines (Fig. 6E; LAI, LAI-YIII, and
LAI-p4). This implies that cell type-specific differences in
the overall level of Vpr-induced activity (Figs. 6C and 6D)
are largely the result of differences in the uninduced
activities of the LAI-based constructs. However, in con-
trast to the LAI constructs, the YU-2-based constructs
exhibit different patterns of Vpr-mediated induction. The
YU-2 LTR exhibits levels of induction similar to the LAI-
based constructs in both cell lines examined (Fig. 6E;
compare LAI and YU-2). The induction of the YU-2-LIII
construct, however, exhibits a strikingly different level of
Vpr-mediated induction in Jurkat and U-937 cells. In Jur-
kat T cells, YU-2-LIII activity was increased 6.2-fold,
whereas in U-937 cells, YU-2-LIII activity was increased
18.5-fold. In a similar manner, the fold-induction of the
YU-2-p4 construct was greater in U-937 cells than in
Jurkat T cells (Fig. 6C; YU-2, YU-2-LIII, YU-2-p4). There-
fore, sequence variants of Sp site III that dramatically
alter Sp factor binding in EMS analysis not only affect
basal LTR activities in a cell type-dependent manner but,
within specific LTR contexts, these elements also may
change the degree of Vpr-mediated transactivation.
Variant cis-acting Sp elements affect Tat-induced
HIV-1 LTR-mediated gene expression
Utilizing the same series of LTR-luciferase constructs
shown in Fig. 5A, the effect of the cis-acting Sp element
on LTR transactivation by the viral transactivator protein
Tat was examined. Since previous reports have indicated
that Tat-mediated transactivation was partially mediated
through the G/C box array of the HIV-1 LTR (Berkhout and
Jeang, 1992), it was hypothesized that configurations of
the NF-kB-proximal Sp site III exhibiting poor factor re-
ruitment would exhibit weaker responses to Tat-medi-
ted LTR activation.
The HIV-1 LAI- and YU-2-based constructs were ex-
mined in cotransfection experiments utilizing expres-
ion constructs for a transactivating Tat (Tat 86) and a
ontransactivating Tat (Tat 48). Expression of Tat 48 did
ot significantly alter the relative activities of the LTR-
uciferase constructs examined by transient expression
compare Figs. 7A and 7B to 5B and 5C). Expression of
at 86 induced LAI LTR activity by 34-fold in U-937 cells
nd by 48-fold in Jurkat cells (Fig. 7E; LAI). In the pres-
nce of Tat 86, LAI LTR activity was greatly reduced upon
ntroduction of the YU-2-derived Sp site III. Specifically, a
5% reduction in activity was observed in U-937 cells,
hereas an 83% reduction in activity was observed in
ground readings, which ranged between 66 and 80, whereas TK-pRL
ET AL.FIG. 7. Transient expression analysis of the Sp site III variants during
transactivation by Tat. Standard reporter gene assays utilizing the dual
luciferase reporter system (see Materials and Methods for details) were
employed to determine the effect of cotransfected Tat on the YU-2-derived
Sp site III (LAI-YIII), and the p4del natural variant Sp site III (LAI-p4) in the
context of parental LAI LTR (LAI) function (A and C). In addition, the effects
of Tat cotransfection on these sites in the context of the YU-2 LTR, which
naturally carries the YU-2-derived Sp site III, were examined (B and D). A
comparison of the activity of constructs in both the Jurkat T cell line and the
U-937 monocytic line in the presence of cotransfected Tat 48 is shown (A
and B). Tat 48 is a truncated Tat construct which exhibits no transactivating
capacity for the HIV-1 LTR; thus this figure approximates the basal activity
shown in Fig. 5. Results are shown as a percentage of LAI LTR activity. A
comparison of the ability of cotransfected Tat to transactivate each of the
variant LTR constructs is shown in both the Jurkat T cell and the U-937
monocytic cell lines (C and D). Results are presented as a percentage of
Tat-induced LAI LTR activity. (E) The fold-induction by Tat of each variant
Sp site III construct is shown. Fold-induction was calculated by dividing
LTR activity in the presence of Tat 86 by LTR activity in the presence of Tat
48. Raw luminescence readings for the LAI construct ranged between
54,437 and 69,604 (uninduced) and 1,531,024 and 2,127,863 (induced) as
compared to background reading, which ranged between 42 and 49 in
Jurkat cells. CMV-pRL Renilla values for those same transfections ranged
from 49,108 to 98,132 as compared to background readings, which ranged
270 MCALLranged from 12,608 to 111,694 as compared to background levels of
2811 to 3201.
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ION OFJurkat T cells (Fig. 7C; compare LAI and LAI-YIII). Simi-
larly, the p4del variant Sp site III resulted in a 36%
reduction in LAI LTR activity in U-937 cells and a 66%
reduction in Jurkat cells (Fig. 7C; compare LAI and LAI-
p4). When the YU-2 LTR construct was examined for
activity in the presence of Tat, a result similar to that
obtained with the LAI-YIII construct was observed. In
U-937 cells, YU-2 LTR activity was 69% lower than that
exhibited by the LAI LTR. Similarly, in Jurkat cells YU-2
LTR activity was 90% lower than LAI LTR activity. The
introduction of a high-affinity cis-acting Sp element
(Jones et al., 1986) into the YU-2 LTR generated a mod-
rate increase in YU-2 LTR activity in U-937 cells, while
roducing a much larger increase in Jurkat T cells. In
-937 cells, YU-2 LTR activity increased 61% when the
III Sp element was introduced. In Jurkat T cells, YU-2
TR activity increased approximately 10-fold (Fig. 7D;
U-2-LIII). Similar to other constructs containing weakly
eactive cis-acting Sp site III variants, the p4del variant
xhibited a greater reduction in activity in the Jurkat cell
ine than in the U-937 cell line (Fig. 7D; YU-2-p4). Con-
istent with the replication characteristics of the recom-
inant HIV-1 molecular clones containing the YIII and p4
p site III variants, these observations indicate an in-
reased dependence on the high-affinity cis-acting Sp
site III in Jurkat T cells as compared to U-937 monocytic
cells.
Results were also expressed as Tat-mediated fold-
induction for each of the constructs examined. With but
one exception, constructs containing high-affinity Sp el-
ements (LAI and YU-2-LIII) supported greater fold-activa-
tion than did their same LTR counterparts containing
lower-affinity elements (LAI-YIII, LAI-p4, YU-2, and YU-2-
p4), when compared within a given cell type. However,
the degree to which this effect was observed was influ-
enced by the cell type. In Jurkat cells, Tat-mediated
fold-induction of the LAI LTR was reduced approximately
twofold by the presence of low-affinity Sp variants,
whereas in U-937 cells, Tat-mediated fold-induction was
relatively unaffected by Sp site III variants [Fig. 7E; com-
pare fold-activation in the Jurkat cell line (LAI, 48-fold;
LAI-YIII, 18-fold; and LAI-p4, 28-fold) to fold-activation in
the U-937 cell line (LAI, 34-fold; LAI-YIII, 27-fold; and
LAI-p4, 38-fold)]. Similarly, but reversed with respect to
cell type, Tat-mediated fold-induction of YU-2 construct
was only moderately affected by Sp site changes in
Jurkat cells compared to the much greater effect ob-
served in U-937 cells [Fig. 7E; compare fold-activation in
the Jurkat cell line (YU-2, 11-fold; YU-2-LIII, 20-fold; and
YU-2-p4, 15-fold) to fold-activation in the U-937 cell line
(YU-2, 14-fold; YU-2-LIII, 60-fold; and YU-2-p4, 32-fold)].
This evidence implies that sequence alterations in Sp
site III can alter the ability of Tat to amplify LTR activity in
DIFFERENTIAL UTILIZATaddition to affecting basal LTR function. Moreover, the
cell type-specific function of Sp site III sequence variantswas mediated during both basal and Tat-induced tran-
scription.
DISCUSSION
During the course of an HIV-1 infection, genetic vari-
ants rapidly evolve based on extensive viral replication
coupled with the high mutational frequency of the re-
verse-transcriptase enzyme and recombination between
diploid genomes. At any given time, this genetic plasticity
is being shaped by selective pressures of immunologi-
cal, physiological, and pharmacologic origin. Together,
these forces generate a virus, which rapidly adapts to its
environment and has been described as swarms of ge-
netically distinct variants existing simultaneously within
single individuals.
Although significant evidence suggests that the viral
envelope adapts to particular cell populations (as re-
viewed by Hoffman and Doms, 1999), less support has
been developed for the idea of LTR evolution and its role
in pathogenesis and disease progression. In the mouse,
retroviral LTR sequences have been demonstrated to
influence infection and disease within the CNS (Portis et
al., 1990). In the HIV-1 system, Ait-Khaled and colleagues
(1995), in a study involving LTR sequences derived from
multiple tissues from a single individual, suggested that
LTRs may evolve in a tissue-compartmentalized manner.
Evidence that LTR sequences derived from brain are
functionally distinct from blood-derived LTRs also exists.
Corboy and colleagues (1992) demonstrated in a trans-
genic mouse model that CNS-derived LTRs drove ex-
pression of a reporter gene in the CNS, whereas a
blood-derived LTR did not. Phylogenetic analysis of a
number of LTRs derived from brain tissue of four individ-
uals, however, did not reveal any simple association
between specific nucleotides of brain-derived se-
quences and the CNS clones used in the transgenic
experiments, making it difficult to ascribe CNS-specific
function to specific cis-acting transcriptional control ele-
ments within the LTR (Corboy and Garl, 1997). However,
because a variety of sequence alterations may result in
similar phenotypic effects involving a particular cis-act-
ing element (e.g., increased/decreased factor recruit-
ment, or enhanced/reduced affinity for an alternate fac-
tor), it is not surprising that simple associations between
a particular nucleotide alteration and specific LTRs are
difficult to identify based on sequence analysis alone.
Rather, one might expect that a constellation of se-
quence alterations producing similar phenotypes would
be selected for during adaptation to new environments.
Hence, reports which exclude the possibility of cell type-
specific LTR adaptation, based on simple nucleotide
comparisons in the absence of any biochemical or func-
tional studies, may be excluding an important element
271HIV-1 LTR Sp SITE IIIfrom their analyses.
The impact of the relative affinity of the NF-kB-proxi-
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ISTERmal Sp element for members of the Sp family of tran-
scription factors on viral replication and gene expression
was examined in two cell lines selected as models of the
two most prominent cell populations that support viral
replication during the natural course of HIV-1 infection.
Recombinant HIV-1 molecular clones containing low-
affinity Sp elements at site III exhibited significant reduc-
tions in the magnitude of viral production coupled with
an increased lag before detectable levels of virus were
produced in the Jurkat T cell line. The same viral con-
structs exhibited only minor reductions in the magnitude
of viral production during replication in U-937 monocytic
cells. These results were supported by studies utilizing
LTR-driven reporter genes, which demonstrated a high-
affinity Sp site III element was of greater importance to
LTR function in Jurkat T cells than in U-937 monocytic
cells, and by studies of Vpr- and Tat-mediated LTR acti-
vation. In summary, these experimental observations in-
dicate that the cellular environments present in the Jurkat
T cell and U-937 monocytic cell vary with respect to their
ability to support transcription from HIV-1 LTRs contain-
ing alterations which reduce Sp factor recruitment at the
NF-kB-proximal Sp element. The differences in the tran-
scriptional environment between these two cell types
provide a potential opportunity for HIV-1 to alter its LTR
structure through sequence variation and selective pres-
sure to better utilize the transcriptional environment
present in each cell type. The Sp site III variants exam-
ined exhibited reduced viral replication in both cell types.
However, the difference in the magnitude of this effect
indicated that alterations to the Sp site III were better
tolerated in the U-937 cell line and, since U-937 cells are
a model for cells of the monocytic lineage, were possibly
better tolerated in monocytic cells. In addition, if the LTR
evolves secondary to envelope-mediated tropism, one
might expect that the frequency of variant Sp elements
found in LTRs derived from M-tropic viruses would ex-
ceed the frequency of such changes in T-tropic viruses.
This hypothesis may provide an interesting avenue for
the investigation of cell type-specific LTR evolution. How-
ever, because of the paucity of available confirmed M-
tropic LTR sequences, directly assessing this prediction
is currently difficult to any degree of statistical certainty.
It is interesting to consider what aspects of the tran-
scriptional environment within the Jurkat and U-937 cell
lines may account for the difference in the behavior of
the Sp variant viruses between the cell lines. It is intuitive
to first consider potential differences in the levels of Sp
factors present in each cell type. Although Sp factors
were long thought to be basal transcription factors,
whose purpose was the steady direction of housekeep-
ing gene expression, recent evidence has revealed an
increased complexity within the Sp family of transcription
factors. The Sp family of transcription factors now in-
272 MCALLcludes Sp1, Sp2, Sp3, and Sp4 (Hagen et al., 1992; Kings-
ey and Winoto, 1992). Sp1, Sp3, and Sp4 share near- iquivalent affinity for binding G/C-rich sequences,
hereas Sp2 prefers binding to an alternative G/T-rich
equence (Hagen et al., 1992, 1994; Kingsley and Winoto,
992). Sp1 and Sp3 are ubiquitously expressed, whereas
p4 has been shown to be expressed in a brain-re-
tricted fashion (Hagen et al., 1992). With respect to
IV-1, Sp1 and Sp4 have been shown to function as
ctivators of LTR-driven gene expression, whereas both
he full-length Sp3 and truncated Sp3 isoforms have
een shown to act as repressors (Majello et al., 1994).
ence, competition between Sp1 and Sp3 for a given
is-acting Sp element within the HIV-1 LTR could deter-
ine whether an activating or repressing activity is re-
lized. Differences in the relative amounts of Sp1 and
p3 present in different cell types could help determine
hether an activating or repressing factor dominates
ith respect to a specific cis-acting element. This poten-
ial explanation has been examined and it has been
etermined that the binding of Sp1 relative to both full-
ength and truncated Sp3 remains essentially unchanged
y EMS analysis between Jurkat T cells and U-937 mono-
ytic cells (Millhouse et al., 1998; McAllister et al., in
reparation). However, these results do not exclude the
ossibility that posttranslational alterations such as
hosphorylation or glycosylation (Jackson and Tijan,
988; Jackson et al., 1990) could impact function subse-
quent to binding. Although little is known about how
these modifications may impact Sp factor recruitment
and activity, differences in the levels of such modifica-
tions between the cell lines might be associated with the
differences in replication of the variant viruses.
A second possibility is that the presence or absence of
an Sp factor at the NF-kB-proximal Sp element might
exert varying influences on the ability of the LTR to utilize
NF-kB within the two cellular environments. This idea is
supported by the finding that the induction of LTR activity
by various mitogens has been shown to be dependent
on protein–protein interactions between NF-kB and Sp1
actors (Perkins et al., 1993). Finally, it is possible that
lterations in factors other than those of the Sp family
ould account for the alteration in activity of the Sp site
ariant viruses. If LTR activity in one cell type is more
ependent on the basal activation provided by the cis-
cting Sp elements, then the impact on LTR function
enerated by disrupting Sp factor recruitment at a single
ite would be significant. Conversely, if LTR activity in a
iven cell type is less dependent on Sp factors as a
esult of better support by other transcriptional factors,
uch as NF-kB or C/EBP, then the impact of a weak
cis-acting Sp element might be minimized. Studies uti-
lizing mutant viral constructs containing Sp site deletions
in peripheral blood leukocytes (PBLs) and T cell lines
indicate that replication of virus lacking one or more Sp
elements yields a hierarchy of permissiveness (Ross et
ET AL.al., 1991; Parrott et al., 1991). PBLs and MT4 cells exhib-
ted the most permissiveness, while CEM and Jurkat
is-actincells exhibited the least. These studies suggested that
the hierarchy seen likely reflects the relative abundance
of transcription factors present in each cell type relative
to the available cis-acting elements of a given LTR.
These results imply that low levels of NF-kB in unstimu-
lated Jurkat T cells might influence the impact of the
altered cis-acting Sp element. In addition, utilization of
the C/EBP family of transcription factors by HIV-1 LTRs in
monocytic cells may reduce the dependence on Sp and
NF-kB factors observed in T cells. Despite the impor-
tance of C/EBP factors with respect to HIV-1 LTR function
in monocytes (Henderson and Calame, 1997), such an
effect is unlikely in T cell lines since EMS analysis has
demonstrated that Jurkat T cells exhibit less C/EBP bind-
ing activity than do U-937 monocytic cells (data not
shown).
Another interesting observation in the studies reported
herein was the resultant basal activity of the YU-2 LTR
after the normally weak NF-kB-proximal Sp element was
replaced by a strong (clade B consensus) Sp element.
The reporter gene activity of the YU-2 LTR increased from
60 to 300% of the activity of the LAI LTR with the intro-
duction of the clade B consensus Sp site III in Jurkat T
cells, which represents a fivefold elevation in basal ac-
tivity. Conversely, in the U-937 monocytic cells the activity
of the YU-2 LTR decreased from 80 to 25% of the activity
of the LAI LTR. These observations indicated that for
basal LTR-driven gene expression a strong Sp site III
element was detrimental in the U-937 cell line, while
greatly advantageous in Jurkat T cells. Interestingly, this
result was not paralleled in the LAI LTR. Although intro-
FIG. 8. Sequence comparison of the HIV-1 YU-2 and LAI LTRs. Diag
alterations (substitutions and insertions/deletions) are depicted as ve
These alterations are shown in relation to the location of numerous c
Krebs et al., 1998) for rapid comparison.
DIFFERENTIAL UTILIZATduction of the YU-2-derived Sp site III into the LAI LTR
generated a 60% decrease in basal activity in Jurkat Tcells, the same alteration did not generate an increase in
LTR activity when expressed in U-937 cells. These stud-
ies indicate inherent differences in the LTR backbones,
which influence the effects mediated through the variant
Sp elements. Alignment of the LAI and YU-2 LTRs re-
vealed 31 nucleotide alterations, counting both substitu-
tions and insertions/deletions (Fig. 8). With the exception
of the aforementioned G:A change in the NF-kB-proximal
Sp element (position 275 relative transcriptional initia-
tion), no changes were noted in the core or enhancer
regions. Within the upstream modulatory region a num-
ber of groupings of alterations were observed. First, a
group of four alterations were found between 2110 and
2135, a region occupied by cis-acting elements for
C/EBP and LEF-1. A second large grouping of alterations
was observed between 2200 and 2350, a region con-
taining numerous cis-acting elements, including NF-AT,
C/EBP, AP-1, and the NRE. There is a strong concentra-
tion of alterations grouped within the negative regulatory
element (NRE, 2320 to 2356), a region that normally
exerts a repressive effect on LTR-mediated transcription
(Lu et al., 1990). Specifically, eight nucleotides were mis-
aligned as a result of insertions/deletions totaling five
nucleotides and base-pair substitutions at three posi-
tions. These changes may reduce the effect of the NRE
on YU-2 LTR function to partially compensate for loss of
a strong Sp site III. Such a hypothesis could then be
used to explain the strong elevation in basal activity
generated by the introduction of the clade B consensus
Sp site III to the YU-2 LTR. Future studies will further
examine this hypothesis.
picting a sequence comparison of the YU-2 and LAI LTRs. Nucleotide
nes labeled by their location relative to the start site of transcription.
g elements found in the HIV-1 LTR (cis-acting elements adapted from
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ISTERLTRs. Consistent with previous studies (Harrich et al.,
1989; Kamine et al., 1991) high-affinity Sp site III elements
in both the LAI and YU-2 LTRs yielded greater fold-
activation than did lower-affinity elements in a given cell
type. Tat-mediated activation of these LTRs was modu-
lated by both the relative affinity of the Sp site III element
and cell type in which they were expressed (Fig. 7E).
Interestingly, differences in YU-2 LTR activation among
the Sp site III variants was more apparent in U-937 cells,
whereas differences in LAI LTR activation among the Sp
site III variants was more apparent in Jurkat cells. As with
basal activity, these findings imply inherent functional
differences in the YU-2 and LAI LTRs. These observa-
tions imply that Tat-mediated induction is dependent on
the affinity of the Sp site III element, and that cell type-
specific differences in LTR activity observed in the pres-
ence of Tat were driven by Tat transactivation in addition
to basal transcription.
In contrast to Tat, Vpr-mediated transactivation of the
LAI LTR was unaffected by the relative affinity of the Sp
site III element studied (Fig. 6E). However, Vpr-mediated
induction of the YU-2 LTR exhibited cell-type specificity,
depending on the relative affinity of the Sp site III ele-
ment present (Fig. 6E). Hence, in the context of the LAI
LTR, differences in the activity of Sp site variants in the
presence of Vpr are primarily the result of cell type-
specific differences in basal activity. Alternatively, in the
context of the YU-2 LTR, differences in the activity of Sp
site variants are more likely generated by cell type-
specific effects in Vpr-mediated induction as well as
basal transcription. Although Vpr has been shown to
mediate its transcriptional effects through the Sp array
(Wang et al., 1995), the Sp site-dependent differences in
Vpr-mediated induction observed in the context of the
YU-2, but not the LAI LTR, may imply that elements
outside of the Sp array also influence Vpr-mediated ac-
tivation in certain HIV-1 LTRs. Modulation of Vpr-medi-
ated LTR activity could be the result of a direct interaction
between Vpr and a given cis-acting element, or a protein/
protein interaction between Vpr and a non-Sp transcrip-
tion factor. One potential candidate for such a Vpr-mod-
ulating interaction is the C/EBP family of transcription
factors. Differences in cis-acting C/EBP elements be-
tween the two LTRs (Fig. 8), coupled with the cell type-
restricted pattern of C/EBP expression, make this an
intriguing possibility.
In summary, differences in the utilization of the Sp site
III element between the Jurkat T cell line and the U-937
monocytic cell line illustrate a potential avenue for LTR
sequence variation and adaptation to influence cell type-
specific viral replication. Inherent differences in gene
regulation between the T-tropic HIV-1 LAI-derived LTR
and the M-tropic HIV-1 YU-2-derived LTR further support
this hypothesis. However, additional studies are required
274 MCALLto fully elucidate the potential impact of the HIV-1 LTR on
cell type-specific viral replication and gene regulation.
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WMATERIALS AND METHODS
Cell culture and nuclear extract preparation
The human monocytic line U-937 and the human T cell
line Jurkat were grown in RPMI 1640 media (Sundstrom
and Nilsson, 1976; Nagasawa et al., 1981). HeLa cells
ere grown in Delbecco’s media (Jones et al., 1971). All
edia were supplemented with 10% heat-inactivated fe-
al bovine serum, antibiotics (penicillin, streptomycin,
nd kanamycin at 0.04 mg/ml each), L-glutamine (0.3
g/ml), and sodium bicarbonate (0.05%). All cell lines
ere maintained at 37°C in 90% relative humidity and 5%
O2. Nuclear extracts were prepared (Dignam et al.,
983) and quantitated for protein concentration as de-
cribed (Bradford, 1976). Briefly, exponentially growing
ells were collected by centrifugation, swelled hypoton-
cally, and lysed by Dounce homogenization. Nuclei were
elleted and lysed to extract nuclear proteins, which
ere dialyzed in buffer [HEPES, pH 7.9 (20 mM), glycerol
20% v/v), KCl (100 mM), EDTA (0.2 mM), PMSF (0.2 mM),
nd DTT (0.5 mM)] for 30 min at 4°C.
ligonucleotide probe synthesis and labeling
Complementary single-stranded oligonucleotides
ere synthesized (Macromolecular Core Facility, Penn
tate College of Medicine, Hershey, PA) and annealed by
eating to 95°C followed by gradual cooling to room
emperature. The resulting double-stranded oligonucle-
tides were gel-purified and radiolabeled using T4
olynucleotide kinase (Gibco BRL, Gaithersburg, MD)
nd [g-32P]ATP. The sequences of the probes used in
hese studies were as follows: LIII (LAI Sp site III),
CAGGGAGGCGTGGCCTGGG; YIII (YU-2 Sp site III),
CCAGGGAAGCGTGGCCTGGG; p4del (p4 variant Sp site
III) TCCAGGGAGCGTGGCCTGGG; con BI (clade B con-
sensus Sp site I) GGACTGGGGAGTGGCGAGCC.
EMS analyses
EMS analyses were performed as previously de-
scribed (Garner and Revzin, 1981). Radiolabeled probe
was incubated with nuclear extract (6 mg) and poly (dI-
C, 1 mg) for 20 min at 30°C. DNA–protein complexes
ere resolved by electrophoresis for 2 h at 30 mA and
°C in a 4% nondenaturing polyacrylamide gel, which
as subsequently dried at 80°C for 45 min, and sub-
ected to autoradiography. Competition EMS analyses
ere conducted by adding the indicated molar excess of
nlabeled homologous or heterologous oligonucleotide
robe.
lasmid construction and site-directed mutagenesis
The parental LAI LTR, obtained from Dr. Maureen
oodenow (University of Florida, Gainesville, FL), was
ET AL.loned into the pGL3-Basic Vector (Promega, Madison,
I) to construct LAI-Luc. The parental YU-2 LTR was
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ION OFobtained by Pfu-mediated PCR amplification of the YU-2
molecular clone (Li et al., 1991), obtained from Dr. Dana
Gabuzda (Harvard University, Dana-Farber Cancer Insti-
tute, Boston, MA). Specifically, primers TGCACTGCA-
GACTGGAAGGGCT and CCCTCTAGACTGCTAGAGAT
were used to amplify and subsequently clone the LTR
into the XbaI and PstI sites of a modified multiple cloning
region within the pGL3-Basic Vector, generating YU-2-
Luc. Both the parental YU-2-Luc and the LAI-Luc con-
structs were used as templates for site-directed mu-
tagenesis using the QuickChange mutagenesis kit (Strat-
agene, La Jolla, CA) to construct LAI-YIII-Luc, LAI-p4-Luc,
YU-2-LIII-Luc, and YU-2-p4-Luc. LAI-YIII-Luc contains a
single G to A nucleotide substitution in the NF-kB-prox-
imal Sp site, giving this site the configuration published
for the YU-2 LTR (GAAGCGTGGC) (Li et al., 1991) in the
context of the LAI LTR. LAI-p4-Luc has a single nucleo-
tide deletion at position four of the published sequence
for the LAI-derived Sp site III, giving it the p4del natural
variant Sp site III configuration (GGAGCGTGGC) in the
context of the LAI LTR. YU-2-LIII-Luc contains the clade
B consensus Sp site III (the LAI Sp site III: GAGGCGT-
GGC) in the context of the YU-2 LTR, whereas YU-2-p4-
Luc places the p4del variant in the context of the YU-2
LTR. The sequence of each LTR construct was verified
prior to experimentation. In addition, during the genera-
tion of each of the mutant constructs described, two or
more sequence-confirmed clones were generated and
tested for comparable activity. After establishing that the
clones behaved equivalently, a single clone was se-
lected for detailed experimentation.
Transient transfections and luciferase assays
Cell lines (U-937 or Jurkat) were seeded from expo-
nentially growing, low-passage cultures at 5 3 105
cells/ml growth medium and transfected with Fugene 6
(Boehringer-Mannheim, Indianapolis, IN) in 35-mm
plates (Falcon, Lincoln Park, NJ). Premixed Fugene (94 ml
serum-free RPMI with 6 ml Fugene) was added dropwise
to either 1.5 or 0.5 mg of the experimental luciferase
ector (Jurkat and U-937, respectively) and either 125 ng
RL-CMV or 50 ng pRL-TK Renilla internal control vector
Jurkat and U-937, respectively). After a 15-min incuba-
ion, the Fugene/DNA mixture was added directly to the
ells. Cultures were incubated at 37°C for 24 h. Cell
xtracts were harvested and assayed for luminescence
sing the Femtomaster FB 12 luminometer (Zylux, Pfor-
heim, Germany) as described for the Dual Luciferase
ssay (Promega, Madison, WI). When cotransfection
ith either Vpr or Tat was performed, the additional
xpression constructs were included in the Fugene/DNA
ixture. Vpr-pcDNA3 (an active construct derived from
he HIV-1 89.6 molecular clone) was controlled for by the
DIFFERENTIAL UTILIZATse of Vpr-R73S-pcDNA3 (mutated nontransactivating
onstruct). In both cases, the Vpr expression constructsere added at 10% the level of the experimental LTR-
uciferase vector. The Vpr expression vectors were pro-
ided by Dr. Bassel Sawaya (Temple University, Philadel-
hia, PA). Tat86-pcDNA3 (active construct) transactiva-
ion was controlled for by the use of Tat48-pcDNA3
truncated nontransactivating construct). In both cases,
he Tat expression constructs were added at 20% the
evel of the experimental LTR-luciferase vector. The Tat
xpression vectors used were provided by Dr. Kamel
halili (Temple University). Firefly luminescence was nor-
alized to the Renilla luminescence to control for vari-
bility in transfection efficiency. The results have been
resented with the parental LTR values (LAI-Luc) set to
.0 for each experiment and the relative activity of mu-
agenized LTRs was normalized to this value. Each ex-
erimental point was performed in duplicate within an
xperiment. Error bars indicate the standard deviation of
ata obtained from two independent experiments.
utant molecular clone construction
To generate molecular clone constructs containing
utations within their LTRs, a single LTR construct was
ubcloned from the parental HIV-1 molecular clone. This
ubclone was then used as a template for site-directed
utagenesis using the QuickChange mutagenesis kit
Stratagene, LaJolla, CA). The single LTR construct was
enerated by digesting the LAI molecular clone with
spEI, an enzyme which recognizes a unique site within
he LAI LTR. The resulting fragments (a 9-kb HIV-1
enomic fragment and a 3-kb plasmid backbone frag-
ent) were purified. The smaller fragment containing the
acterial plasmid along with two partial LTRs was ligated
o yield a single LTR plasmid construct. This construct
as then mutated to introduce the YU-2-derived Sp site
II (LAI-YIII) and the p4del Sp site III (LAI-p4). Two sepa-
ate mutagenesis reactions yielded two independently
erived clones of each desired mutant. The sequence of
ll LTR constructs was verified prior to experimentation.
he BspEI site is 59 relative to the G/C box array and,
herefore, reconstruction of full-length molecular clones
rom the 9-kb genomic fragment and the 3-kb mutated
ingle LTR constructs resulted in molecular clones con-
aining alterations in their 39 LTRs (a necessity for pro-
duction of infectious virus containing the desired muta-
tions within the context of the 59 LTR). Two sequence-
confirmed clones of each mutant virus were
reconstructed by ligation. Multiple clones of each of the
resulting full-length constructs were identified by restric-
tion endonuclease analysis and subsequently tested for
the presence of the desired mutation by back-isolating
single LTR constructs from the mutant molecular clones
themselves and sequencing the LTR. Only mutant mo-
275HIV-1 LTR Sp SITE IIIlecular clones, which could be sequence-confirmed in
this manner, were used to generate primary viral stocks.
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ISTERViral replication analysis
Primary viral stocks were generated by transfection of
the molecular clone constructs into HeLa cells. Trans-
fection was performed 24 h after plating 1 3 106 target
ells into flasks (25 cm2; Falcon). Lipofectamine (Pro-
mega) was mixed with molecular clone DNA (15 ml lipo-
ectamine, 7.5 mg DNA in 300 ml of Optimem) and incu-
bated for 30 min before being added to cells in a final
volume of 1.5 ml. After 5 h, the transfection media was
washed off and replaced with Delbecco’s media. Primary
viral stocks were harvested 48 h posttransfection. To
ensure that no cells were carried over, the viral stocks
were subjected to centrifugation and passed through a
0.45-mm filter (Nalgene). Stocks were aliquoted and fro-
en at 270°C. The viral titer of a given stock was deter-
ined by p24 assay (NEN, Boston, MA) performed ac-
ording to manufacturer’s specifications. Amplification of
iral titer was performed by inoculating peripheral blood
eukocytes with primary viral stocks and incubating at
7°C for 18 to 21 days in the presence of PHA (5 mg/ml;
Sigma, St. Louis, MO) and IL-2 (0.5 ng/ml; R&D Systems,
Minneapolis, MN). Amplified viral stocks were harvested
and quantitated as described for primary viral stocks.
Viral infections were initiated with equal amounts of
stock virus, as quantitated by p24 assay. Jurkat and
U-937 cells were inoculated with 200 pg and 100 ng
virus, respectively, and after a 4-h absorption period the
cells were washed with PBS to remove unadsorbed input
virus. Supernatant samples were taken every 2 or 3 days
(Jurkat or U-937, respectively) and assayed for p24 pro-
duction. At each time interval, cells were counted by
standard trypan blue dye exclusion and plated at their
original densities (1.5 3 106 cells/ml, Jurkat; 5 3 105
cells/ml, U-937). The entire volume of replication media
for Jurkat cells and half the volume of replication media
for the U-937 cells were replaced during the reseeding
process.
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